REBECCA SIMPSON: Open Payments
NPI 1710304308 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 35 payments from 16 companies in 2025. Trend: 2023 $1,347 · 2024 $1,093 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $232 |
| ABIOMED | 2 | $87 |
| PFIZER INC. | 4 | $68 |
| Alnylam Pharmaceuticals Inc. | 2 | $55 |
| Abbott Laboratories | 1 | $47 |
| Amgen Inc. | 3 | $46 |
| Cleerly, Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: LEQVIO, ONPATTRO, VYNDAQEL, AVEIR, REPATHA, Cleerly Ischemia, Ozempic, INSPIRE.
Industry payments across FL — which companies pay providers there.
